Page last updated: 2024-08-25

rosiglitazone and Skin Aging

rosiglitazone has been researched along with Skin Aging in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bi, B; Chen, L; Guo, Y; Liu, T; Yang, P; Yang, Q; Zeng, J; Zhou, Y; Zhu, J; Zhu, N	1

Other Studies

1 other study(ies) available for rosiglitazone and Skin Aging

Article	Year
Rosiglitazone ameliorates senescence-like phenotypes in a cellular photoaging model. Journal of dermatological science, 2015, Volume: 77, Issue:3 Topics: Aging; Animals; beta-Galactosidase; Catalase; Cell Cycle Checkpoints; Cell Survival; Cells, Cultured; Collagen Type I; Cyclin-Dependent Kinase Inhibitor p21; Fibroblasts; Hypoglycemic Agents; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Models, Biological; Phenotype; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Skin Aging; Thiazolidinediones; Tumor Suppressor Protein p53; Ultraviolet Rays	2015

Article

Year

Rosiglitazone ameliorates senescence-like phenotypes in a cellular photoaging model.

Journal of dermatological science, 2015, Volume: 77, Issue:3

Topics: Aging; Animals; beta-Galactosidase; Catalase; Cell Cycle Checkpoints; Cell Survival; Cells, Cultured; Collagen Type I; Cyclin-Dependent Kinase Inhibitor p21; Fibroblasts; Hypoglycemic Agents; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Models, Biological; Phenotype; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Skin Aging; Thiazolidinediones; Tumor Suppressor Protein p53; Ultraviolet Rays

2015